Publications

All      Ay      Benedict       Cheroutre       Croft       Crotty      Einav       Grifoni       Hogan       Kronenberg      Lisdestam Arlehamn      Myers      Peters      Rao      Reina      Saphire      Schmiedel      Schoenberger      Sette      Sharma      Shresta      Vijayanand      Weiskopf

Altman             Eschweiler      Hedrick       Kawakami      Ley      Pandurangan      Seumois      Von Herrath      
10/01/2014
  • Journal of Virology

Immunodominance changes as a function of the infecting dengue virus serotype and primary versus secondard infection

Weiskopf D, Angelo MA, Sidney J, Peters B, Shresta S, Sette A
05/01/2015
  • Viruses

A novel iminosugar UV-12 with activity against the diverse viruses influenza and dengue (novel iminosugar antiviral for influenza and dengue)

Warfield KL, Plummer E, Alonzi DS, Wolfe GW, Sampath A, Nguyen T, Butters TD, Enterlein SG, Stavale EJ, Shresta S, Ramstedt U
05/01/2015
  • Journal of Virology

Dengue viral evolution under a hose-targeted antiviral

Plummer E, Buck MD, Sanchez M, Greenbaum JA, Turner J, Frewal R, Klose B, Sampath A, Warfield KL, Peters B, Ramstedt U, Shresta S
06/01/2015
  • Journal of Virology

CD8+ T cells can mediate short-term protection against heterotypic dengue reinfection in mice

Zellweger RM, Tang WW, Eddy WE, King K, Sanchez MC, Shresta S
07/01/2015
  • Scientific Reports

Protection against dengue disease by synthetic nucleic acid antibody prophylaxis/immunotherapy

Flingai S, Plummer EM, Patel A, Shresta S, Mendoza JM, Broderick KE, Sardesai NY, Muthumani K, Weiner DB
07/01/2015
  • Journal of Immunology

Different STAT transcription complexes drive early and delayed responses to type I IFNs

Abdul-Sater AA, Majoros A, Plumlee CR, Perry S, Gu AD, Lee C, Shresta S, Decker T, Schindler C
07/07/2015
  • Critical Reviews in Immunology

Innate antiviral immunity against dengue virus

Makhluf H, Shresta S
08/01/2015
  • Current Opinion in Virology

Influence of antibodies and T cells on dengue disease outcome: insights from interferon receptor-deficient mouse models

Tang WW, Grewal R, Shresta S
09/01/2015
  • mBio

Defining new therapeutics using a more immunocompetent mouse model of antibody-enhanced dengue virus infection

Pinto AK, Brien JD, Lam CY, Johnson S, Chiang C, Hiscott J, Sarathy VV, Barrett AD, Shresta S, Diamond MS
05/16/2016
  • Antiviral Res

Inhibition of endoplasmic reticulum glucosidases is required for in vitro and in vivo dengue antiviral activity by th eiminosugar UV-4

Warfield KL, Plummer EM, Sayce AC, Alonzi DS, Tang W, Tyrrell BE, Hill ML, Caputo AT, Killingbeck SS, Beatty PR, Harris E, Iwaki R, Kinami K, Ide D, Kiappes JL, Kato A, Buck MD, King K, Eddy W, Khaliq M, Sampath A, Treston AM, Dwek RA, Enterlein SG, Miller JL, Zitzmann N, Ramstedt U, Shresta S
08/16/2016
  • Trends Microbiol

Neuroterartogenic viruses and lessons for zika virus models

Kim K, Shresta S
08/17/2016
  • Cell Stem Cell

Zika virus infects neural progenitors in the adult mouse brain and alters proliferation

Li H, Saucedo-Cuevas L, Regla-Nava JA, Chai G, Sheets N, Tang W, Terskikh AV, Shresta S, Gleeson JG